Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.

MLA

Glasziou, Paul P., et al. “Cost-Effectiveness of Lowering Blood Pressure with a Fixed Combination of Perindopril and Indapamide in Type 2 Diabetes Mellitus: An ADVANCE Trial-Based Analysis.” The Medical Journal of Australia, vol. 193, no. 6, Sept. 2010, pp. 320–24. EBSCOhost, https://doi.org/10.5694/j.1326-5377.2010.tb03941.x.

APA

Glasziou, P. P., Clarke, P., Alexander, J., Rajmokan, M., Beller, E., Woodward, M., Chalmers, J., Poulter, N., & Patel, A. (2010). Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis. The Medical Journal of Australia, 193(6), 320–324. https://doi.org/10.5694/j.1326-5377.2010.tb03941.x

Chicago

Glasziou, Paul P, Philip Clarke, Jan Alexander, Mohana Rajmokan, Elaine Beller, Mark Woodward, John Chalmers, Neil Poulter, and Anushka Patel. 2010. “Cost-Effectiveness of Lowering Blood Pressure with a Fixed Combination of Perindopril and Indapamide in Type 2 Diabetes Mellitus: An ADVANCE Trial-Based Analysis.” The Medical Journal of Australia 193 (6): 320–24. doi:10.5694/j.1326-5377.2010.tb03941.x.